CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer's disease.

Publication Year: 2024

DOI:
10.1038/s41398-024-02785-3

PMCID:
PMC10853183

PMID:
38331937

Journal Information

Full Title: Transl Psychiatry

Abbreviation: Transl Psychiatry

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychiatry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the single-nucleus gene counts and metadata available from cain et al [ ] on synapse (id: syn16780177) were converted into a seurat object [ ] in r studio for further processing."

Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by the Canadian Institutes of Health Research (CIHR; PJT-153101, EKL and JM; MOP89825, EKL; NGN-171423, ST; PJT-428404, DF), Krembil Foundation (DF, ST), Koerner Family Foundation (DF), CAMH Discovery Fund (DF, ST), Kavli Foundation (ST), McLaughlin Foundation (ST), Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-05834 and DGECR-2020-00048; ST). JM is supported by the Canadian Research Chairs program, as a Tier 1 Chair. ROS/MAP is supported by P30AG10161, P30AG72975, R01AG15819, R01AG17917. U01AG46152, U01AG61356. Author contributions: Conceptualization: JR, ST, DF, EKL; Method development: TH, PDJ, JAS, YW, DAB, ST, DF; Resources: TH, PDJ, JAS, YW, DAB; Data organization and cleaning: JR, YC, MM, EST. Data analysis: JR, YC, EST, ST, DF, EKL; Visualization: JR, ST, DF, EKL. Funding: ST, DF, EKL. Supervision: JM, ST, DF, EKL. Writing—Original Draft: JR, ST, DF, EKL. Writing - review and editing: All authors were involved in the review and editing of the final manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025